Good morning, everyone, and thank you for joining us today. Earlier this morning, we issued a press release outlining the positive topline results from our SOL-1 Phase III clinical trial of AXPAXLI, ...

First ever successful demonstration of superiority in an FDA-aligned wet AMD trial comparing a novel investigative agent to an approved anti-VEGF ...

Through skiing and snowboarding, a local nonprofit strives to provide a new therapeutic avenue for veterans suffering from the calamities of war.

AXPAXLI (TM) (also known as OTX-TKI) is an investigational, bioresorbable, intravitreal hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase inhibitor with anti-angiogenic ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Rory Evans Rory Evans is a writer focused on skin-care and beauty products.

Permanent vision loss in giant cell arteritis is a complication that is often avoidable with prompt diagnosis and treatment.

LASIK offers an example of how ophthalmology is becoming data-driven, using advanced imaging to move beyond static ...

Edinburgh Biosciences has reported encouraging early outcomes from a structured long-term safety and performance follow-up ...

All patients dosed with SPVN06 in Phase I/II trial continue to demonstrate a favorable safety profile ...

Idaho Health and Welfare imposed 20-session caps on Medicaid therapy coverage. Families and providers warn caps, prior authorization could delay or reduce care. Advocates say limits risk regression, ...

View post: The One Workout Mistake Most Guys Make in Their 30s and Pay For in Their 40s, According to a Veteran Trainer If you pay even a little attention to the health and wellness space, you’ve ...

A University of Michigan AI model diagnoses more than 50 brain disorders from MRI scans in seconds, with up to 97.5 percent accuracy.